Chugai Pharmaceutical Co. Reports Findings in Multiple Sclerosis (Interleukin-6: evolving role in the management of neuropathic pain in neuroimmunological disorders).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Source:
    Asia Business Newsweekly. 2021, pages. 71